Skip to main content

Table 3 Identity of FPMSC isolation under GMP requirements

From: Optimizing mesenchymal stem cell therapy: from isolation to GMP-compliant expansion for clinical application

Sample ID

W455623000021

W455623000032

W455623000038

W455623000040

Average

CD73+ (%, > 95%)

97.97

97.31

98.09

98.07

97.86 ± 0.37

CD90+ (%, > 95%)

89.81

97.44

98.07

98.14

95.87 ± 4.05

CD105+ (%, > 95%)

96.77

77.17

97.97

92.93

91.21 ± 9.60

HLA-DR < 5%

0.42

0.63

1.66

1.21

0.98 ± 0.56

Back to article page

BMC Molecular and Cell Biology

ISSN: 2661-8850

Contact us